196 related articles for article (PubMed ID: 26714563)
1. The role of structural proteomics in vaccine development: recent advances and future prospects.
Donnarumma D; Faleri A; Costantino P; Rappuoli R; Norais N
Expert Rev Proteomics; 2016; 13(1):55-68. PubMed ID: 26714563
[TBL] [Abstract][Full Text] [Related]
2. Modern mass spectrometry-based structural proteomics.
Petrotchenko EV; Borchers CH
Adv Protein Chem Struct Biol; 2014; 95():193-213. PubMed ID: 24985773
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry-based structural proteomics.
Serpa JJ; Parker CE; Petrotchenko EV; Han J; Pan J; Borchers CH
Eur J Mass Spectrom (Chichester); 2012; 18(2):251-67. PubMed ID: 22641729
[TBL] [Abstract][Full Text] [Related]
4. Proteomics approaches towards antigen discovery and vaccine development.
Klade CS
Curr Opin Mol Ther; 2002 Jun; 4(3):216-23. PubMed ID: 12139306
[TBL] [Abstract][Full Text] [Related]
5. Protein Structural Analysis via Mass Spectrometry-Based Proteomics.
Artigues A; Nadeau OW; Rimmer MA; Villar MT; Du X; Fenton AW; Carlson GM
Adv Exp Med Biol; 2016; 919():397-431. PubMed ID: 27975228
[TBL] [Abstract][Full Text] [Related]
6. [Progress in structural proteomics research].
Zhou Y; Liu Z; Wang F
Se Pu; 2019 Aug; 37(8):788-797. PubMed ID: 31642248
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of molecular targets of natural products by mass spectrometry.
Cheng KW; Wong CC; Wang M; He QY; Chen F
Mass Spectrom Rev; 2010; 29(1):126-55. PubMed ID: 19319922
[TBL] [Abstract][Full Text] [Related]
8. Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens.
Liljeroos L; Malito E; Ferlenghi I; Bottomley MJ
J Immunol Res; 2015; 2015():156241. PubMed ID: 26526043
[TBL] [Abstract][Full Text] [Related]
9. Structural vaccinology: a three-dimensional view for vaccine development.
Cozzi R; Scarselli M; Ferlenghi I
Curr Top Med Chem; 2013; 13(20):2629-37. PubMed ID: 24066888
[TBL] [Abstract][Full Text] [Related]
10. Higher order structure characterization of protein therapeutics by hydrogen/deuterium exchange mass spectrometry.
Huang RY; Chen G
Anal Bioanal Chem; 2014 Oct; 406(26):6541-58. PubMed ID: 24948090
[TBL] [Abstract][Full Text] [Related]
11. Mapping Protein-Ligand Interactions with Proteolytic Fragmentation, Hydrogen/Deuterium Exchange-Mass Spectrometry.
Gallagher ES; Hudgens JW
Methods Enzymol; 2016; 566():357-404. PubMed ID: 26791987
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen-deuterium exchange mass spectrometry for determining protein structural changes in drug discovery.
Lee JJ; Park YS; Lee KJ
Arch Pharm Res; 2015 Oct; 38(10):1737-45. PubMed ID: 25743629
[TBL] [Abstract][Full Text] [Related]
13. [Application of reverse vaccinology in Schistosoma vaccine development: advances and prospects].
Feng XG; Sui CY; Yuan CX; Shao DH; Chen JX; Lin JJ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):237-47. PubMed ID: 18038788
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping by differential chemical modification of antigens.
Dhungana S; Fessler MB; Tomer KB
Methods Mol Biol; 2009; 524():119-34. PubMed ID: 19377941
[TBL] [Abstract][Full Text] [Related]
15. Chemical biology approaches to designing defined carbohydrate vaccines.
Anish C; Schumann B; Pereira CL; Seeberger PH
Chem Biol; 2014 Jan; 21(1):38-50. PubMed ID: 24439205
[TBL] [Abstract][Full Text] [Related]
16. Designing the next generation of vaccines for global public health.
Bagnoli F; Baudner B; Mishra RP; Bartolini E; Fiaschi L; Mariotti P; Nardi-Dei V; Boucher P; Rappuoli R
OMICS; 2011 Sep; 15(9):545-66. PubMed ID: 21682594
[TBL] [Abstract][Full Text] [Related]
17. Structure and Computation in Immunoreagent Design: From Diagnostics to Vaccines.
Gourlay L; Peri C; Bolognesi M; Colombo G
Trends Biotechnol; 2017 Dec; 35(12):1208-1220. PubMed ID: 28739221
[TBL] [Abstract][Full Text] [Related]
18. PepShell: visualization of conformational proteomics data.
Vandermarliere E; Maddelein D; Hulstaert N; Stes E; Di Michele M; Gevaert K; Jacoby E; Brehmer D; Martens L
J Proteome Res; 2015 Apr; 14(4):1987-90. PubMed ID: 25728987
[TBL] [Abstract][Full Text] [Related]
19. Unraveling the dynamics of protein interactions with quantitative mass spectrometry.
Ramisetty SR; Washburn MP
Crit Rev Biochem Mol Biol; 2011 Jun; 46(3):216-28. PubMed ID: 21438726
[TBL] [Abstract][Full Text] [Related]
20. Proteomics for development of vaccine.
Adamczyk-Poplawska M; Markowicz S; Jagusztyn-Krynicka EK
J Proteomics; 2011 Nov; 74(12):2596-616. PubMed ID: 21310271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
